These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26822308)

  • 1. A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.
    Pidugu LS; Mbimba JC; Ahmad M; Pozharski E; Sausville EA; Emadi A; Toth EA
    BMC Struct Biol; 2016 Jan; 16():1. PubMed ID: 26822308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
    Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
    J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis.
    Huang X; Dong Y; Bey EA; Kilgore JA; Bair JS; Li LS; Patel M; Parkinson EI; Wang Y; Williams NS; Gao J; Hergenrother PJ; Boothman DA
    Cancer Res; 2012 Jun; 72(12):3038-47. PubMed ID: 22532167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
    Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
    Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G; Amzel LM
    Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkynyloxy derivatives of 5,8-quinolinedione: Synthesis, in vitro cytotoxicity studies and computational molecular modeling with NAD(P)H:Quinone oxidoreductase 1.
    Kadela-Tomanek M; Jastrzębska M; Pawełczak B; Bębenek E; Chrobak E; Latocha M; Książek M; Kusz J; Boryczka S
    Eur J Med Chem; 2017 Jan; 126():969-982. PubMed ID: 28006669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
    Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
    J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.
    Gong Q; Yang F; Hu J; Li T; Wang P; Li X; Zhang X
    Eur J Med Chem; 2021 Nov; 224():113707. PubMed ID: 34303080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugs.
    Phillips RM; Jaffar M; Maitland DJ; Loadman PM; Shnyder SD; Steans G; Cooper PA; Race A; Patterson AV; Stratford IJ
    Biochem Pharmacol; 2004 Dec; 68(11):2107-16. PubMed ID: 15498501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death.
    Froeling FEM; Swamynathan MM; Deschênes A; Chio IIC; Brosnan E; Yao MA; Alagesan P; Lucito M; Li J; Chang AY; Trotman LC; Belleau P; Park Y; Rogoff HA; Watson JD; Tuveson DA
    Clin Cancer Res; 2019 Dec; 25(23):7162-7174. PubMed ID: 31527169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
    Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
    Pradubyat N; Sakunrangsit N; Mutirangura A; Ketchart W
    Phytomedicine; 2020 Jan; 66():153133. PubMed ID: 31790893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1.
    Kolossov VL; Ponnuraj N; Beaudoin JN; Leslie MT; Kenis PJ; Gaskins HR
    Biochem Biophys Res Commun; 2017 Jan; 483(1):680-686. PubMed ID: 27986568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxynyboquinones as NQO1-Activated Cancer Therapeutics.
    Parkinson EI; Hergenrother PJ
    Acc Chem Res; 2015 Oct; 48(10):2715-23. PubMed ID: 26444384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.
    Pey AL; Megarity CF; Timson DJ
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of cooperative binding of FAD to human NQO1: Implications to understanding cofactor-dependent function and stability of the flavoproteome.
    Clavería-Gimeno R; Velazquez-Campoy A; Pey AL
    Arch Biochem Biophys; 2017 Dec; 636():17-27. PubMed ID: 29100982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.).
    Lienhart WD; Gudipati V; Uhl MK; Binter A; Pulido SA; Saf R; Zangger K; Gruber K; Macheroux P
    FEBS J; 2014 Oct; 281(20):4691-4704. PubMed ID: 25143260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel NQO1 substrates bearing two nitrogen redox centers: Design, synthesis, molecular dynamics simulations, and antitumor evaluation.
    Gong Q; Wang P; Li T; Yu Z; Yang L; Wu C; Hu J; Yang F; Zhang X; Li X
    Bioorg Chem; 2023 May; 134():106480. PubMed ID: 36958178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.
    Ross AE; Emadi A; Marchionni L; Hurley PJ; Simons BW; Schaeffer EM; Vuica-Ross M
    BJU Int; 2011 Aug; 108(3):447-54. PubMed ID: 21176082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.